THE MEDICAL COST OF OSTEOARTHRITIS AND RHEUMATOID ARTHRITIS- METHODS AND EVIDENCE
Author(s)
Lee DW2, Meyer J1, Clouse, J1; 1Ingenix, Eden Prairie, MN, USA; 2GD Searle, Skokie, IL, USA
OBJECTIVE: To evaluate the impact of controlling and not controlling for comorbid conditions on the estimated cost of osteoarthritis (OA) and rheumatoid arthritis (RA) in a managed care setting. METHODS: Medical claims data from 1996 were obtained for inpatient, outpatient and pharmacy services for members in five United Health-affiliated health plans (enrollment: 884,000). Total costs for arthritis patients (>1 claims with an arthritis diagnosis and ?30 days of continuous enrollment) were compared to costs among an equal number of comparison members who were selected at random after stratification by health plan, gender, age category, and Medicare status. Multivariate regression analysis was used to compare the natural log of costs between the two groups under three alternative controls for comorbid conditions--no controls, controls for all conditions, and controls for conditions thought to be unrelated to arthritis. RESULTS: 5,920 OA and 1,310 RA patients were identified. OA patients cost between 1.50 and 2.56 times more than non-arthritis patients, while RA patients cost between 2.21 and 3.07 times more than non-arthritis patients. Based on assumptions about the relationships between comorbid conditions and arthritis, our point estimate is that OA adds $80 per-patient-per-month (PPPM) compared to non-arthritis patients, while RA adds $109 PPPM compared to non-arthritis patients. CONCLUSIONS: Arthritis increases the costs of care significantly. Existing estimation approaches either underestimate the cost of arthritis by including the cost of all comorbid conditions, or overestimate the cost by excluding the cost of all comorbid conditions. Our approach, which controls for only those comorbid conditions which are unrelated to arthritis, yields a cost estimates that fall between those estimated by existing approaches and is believed to be more precise.
Conference/Value in Health Info
1999-05, ISPOR 1999, Arlington, VA, USA
Value in Health, Vol. 2, No. 3 (May/June 1999)
Code
TPIL3
Topic
Economic Evaluation
Topic Subcategory
Cost/Cost of Illness/Resource Use Studies
Disease
Musculoskeletal Disorders